Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Anthony David Elias

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Elias, Anthony

Item TypeName
Academic Article The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapy.
Academic Article High-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy: analysis by age.
Academic Article Repetitive cycles of cyclophosphamide, thiotepa, and carboplatin intensification with peripheral-blood progenitor cells and filgrastim in advanced breast cancer patients.
Academic Article Double dose-intensive chemotherapy with autologous stem-cell support for metastatic breast cancer: no improvement in progression-free survival by the sequence of high-dose melphalan followed by cyclophosphamide, thiotepa, and carboplatin.
Academic Article Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer.
Academic Article High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma.
Academic Article High-dose chemotherapy with autologous stem cell support for breast cancer: a review of the Dana-Farber Cancer Institute/Beth Israel Hospital experience.
Academic Article Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.
Academic Article The interval between courses of high-dose chemotherapy with stem cell rescue: therapeutic hypotheses.
Academic Article Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer.
Academic Article Status of high-dose chemotherapy for breast cancer: a review.
Academic Article GM-CSF potentiated peripheral blood progenitor cell (PBPC) collection with or without bone marrow as hematologic support of high-dose chemotherapy: two protocols.
Academic Article A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy.
Academic Article Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer.
Academic Article High dose chemotherapy with stem cell rescue for breast cancer: current status and future directions.
Academic Article High-dose thiotepa alone and in combination regimens with bone marrow support.
Academic Article Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients.
Academic Article A phase I-II study of cyclophosphamide, thiotepa, and carboplatin with autologous bone marrow transplantation in solid tumor patients.
Academic Article A young woman with a small ER-positive breast cancer, a micrometastatic axillary lymph node, and an intermediate oncotype DX recurrence score.
Academic Article Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
Academic Article A perimenopausal woman with a small, ER/HER2-positive, node-negative breast cancer.
Academic Article Evaluation of monoclonal antibody DF3 conjugated with ricin as a specific immunotoxin for in vitro purging of human bone marrow.
Academic Article Early-stage BRCA2-linked breast cancer diagnosed in the first trimester of pregnancy associated with a hypercoagulable state.
Academic Article Triple-negative breast cancer: a short review.
Academic Article A phase II trial of pemetrexed and gemcitabine in patients with metastatic breast cancer who have received prior taxane therapy.
Academic Article Cytokeratin 5 positive cells represent a steroid receptor negative and therapy resistant subpopulation in luminal breast cancers.
Academic Article Double high-dose chemotherapy with stem cell rescue (HD-SCR) in patients with breast cancer - effect of sequence.
Academic Article Detection and analysis of cancer cells in blood and bone marrow using a rare event imaging system.
Academic Article Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response.
Academic Article Diagnosis of invasive lobular carcinoma in a young woman presenting with pleomorphic lobular carcinoma in situ on core biopsy.
Academic Article A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.
Academic Article MicroRNAs link estrogen receptor alpha status and Dicer levels in breast cancer.
Academic Article The era of high-dose chemotherapy for breast cancer: revisiting a troubled quest.
Academic Article The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.
Academic Article High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer.
Academic Article Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study.
Academic Article A postmenopausal woman with early-stage breast cancer and borderline hormone-receptor staining.
Academic Article Outcome of patients with metastatic breast carcinoma treated at a private medical oncology clinic.
Academic Article Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer.
Academic Article A woman with primary breast cancer and a solitary sternal metastasis.
Academic Article Multistep tumorigenesis and the microenvironment.
Academic Article Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest Oncology Group/Intergroup study 9623.
Academic Article Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance.
Academic Article Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: tamoxifen agonist effects dominate in the presence of an aromatase inhibitor.
Academic Article Discovery and verification of protein differences between Er positive/Her2/neu negative breast tumor tissue and matched adjacent normal breast tissue.
Academic Article An open-label, phase 2 trial of RPI.4610 (Angiozyme) in the treatment of metastatic breast cancer.
Academic Article Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.
Academic Article Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development.
Academic Article Reducing breast cancer recurrence with weight loss, a vanguard trial: the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial.
Concept Breast Neoplasms, Male
Concept Breast Neoplasms
Academic Article Metaplastic mammary carcinoma with discrepant hormone receptor results by IHC and RT-PCR.
Academic Article High-dose combination alkylating agent preparative regimen with autologous bone marrow support: the Dana-Farber Cancer Institute/Beth Israel Hospital experience.
Academic Article Randomized phase II study of sunitinib versus standard of care for patients with previously treated advanced triple-negative breast cancer.
Academic Article Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer.
Academic Article Breast cancer version 3.2014.
Academic Article Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide.
Academic Article Trastuzumab emtansine and stereotactic radiosurgery: an unexpected increase in clinically significant brain edema.
Academic Article Management of young breast cancer patients with de novo genetic mutations.
Academic Article Breast Cancer Version 2.2015.
Academic Article Multiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivo.
Academic Article The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer.
Academic Article Multiple Hepatic Lesions in a Patient With a History of DCIS.
Academic Article Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivors.
Academic Article Androgen Receptor Biology in Triple Negative Breast Cancer: a Case for Classification as AR+ or Quadruple Negative Disease.
Academic Article Quality of life outcomes from the Exercise and Nutrition Enhance Recovery and Good Health for You (ENERGY)-randomized weight loss trial among breast cancer survivors.
Academic Article NCCN Guidelines Insights Breast Cancer, Version 1.2016.
Academic Article Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.
Academic Article Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer.
Academic Article A 55-Year-Old Woman With New Triple-Negative Breast Mass, Less Than 2 cm on Both Mammogram and Ultrasound.
Academic Article 21-Gene Recurrence Score Assay As a Predictor of Adjuvant Chemotherapy Administration for Early-Stage Breast Cancer: An Analysis of Use, Therapeutic Implications, and Disparity Profile.
Academic Article Impact of a behavioral weight loss intervention on comorbidities in overweight and obese breast cancer survivors.
Academic Article Adaptive Randomization of Neratinib in Early Breast Cancer.
Academic Article Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.
Academic Article Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources.
Academic Article Anti-androgen therapy in triple-negative breast cancer.
Academic Article Dicer expression in estrogen receptor-positive versus triple-negative breast cancer: an antibody comparison.
Academic Article Fibroblast Subtypes Regulate Responsiveness of Luminal Breast Cancer to Estrogen.
Academic Article Cooperative Dynamics of AR and ER Activity in Breast Cancer.
Academic Article Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing Strategies.
Academic Article A Phase I/Ib Study of Enzalutamide Alone and in Combination with Endocrine Therapies in Women with Advanced Breast Cancer.
Academic Article NCCN Guidelines Insights: Breast Cancer, Version 1.2017.
Academic Article The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?
Grant SOLID TUMOR AUTOLOGOUS MARROW PROGRAM
Grant University of Colorado Southwest Oncology Group
Academic Article Androgen Receptor Supports an Anchorage-Independent, Cancer Stem Cell-like Population in Triple-Negative Breast Cancer.
Academic Article Synergy between Androgen Receptor Antagonism and Inhibition of mTOR and HER2 in Breast Cancer.
Academic Article Isolation of Breast cancer CTCs with multitargeted buoyant immunomicrobubbles.
Academic Article Triple-negative breast cancer in the elderly.
Academic Article Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer.
Academic Article Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG).
Academic Article Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.
Academic Article Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG).
Academic Article NCCN Guidelines Updates: Breast Cancer.
Academic Article FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation.
Academic Article A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer.
Academic Article Male breast cancer: a disease distinct from female breast cancer.
Academic Article NCCN Guidelines Insights: Breast Cancer, Version 3.2018.
Concept Triple Negative Breast Neoplasms
Academic Article Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307.
Academic Article MK-2206 and Standard Neoadjuvant Chemotherapy Improves Response in Patients With Human Epidermal Growth Factor Receptor 2-Positive and/or Hormone Receptor-Negative Breast Cancers in the I-SPY 2 Trial.
Academic Article Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer: An Analysis of the Ongoing Phase 2 Adaptively Randomized I-SPY2 Trial.
Academic Article Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
Academic Article Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.
Academic Article Analysis of circulating breast cancer cell heterogeneity and interactions with peripheral blood mononuclear cells.
Academic Article Clinical outcomes of breast cancer patients treated in phase I clinical trials at University of Colorado Cancer Center.
Academic Article Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer.
Academic Article Activity of Combined Androgen Receptor Antagonism and Cell Cycle Inhibition in Androgen Receptor Positive Triple Negative Breast Cancer.
Academic Article Updated Standardized Definitions for Efficacy End Points (STEEP) in Adjuvant Breast Cancer Clinical Trials: STEEP Version 2.0.
Academic Article Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial.
Academic Article Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer.
Academic Article Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial.
Academic Article Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial.
Academic Article NCCN Guidelines? Insights: Breast Cancer, Version 4.2021.
Academic Article Neoadjuvant endocrine therapy expands stromal populations that predict poor prognosis in estrogen receptor-positive breast cancer.
Academic Article Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials.
Academic Article Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer.
Academic Article Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Academic Article Biomarkers for Systemic Therapy in Metastatic Breast Cancer: ASCO Guideline Update.
Academic Article Safety and efficacy of HSP90 inhibitor ganetespib for neoadjuvant treatment of stage II/III breast cancer.
Academic Article Clinical outcomes of adjuvant taxane plus anthracycline versus taxane-based chemotherapy regimens in older adults with node-positive, triple-negative breast cancer: A SEER-Medicare study.
Academic Article Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer.
Academic Article NCCN Guidelines? Insights: Breast Cancer, Version 4.2023.
Academic Article Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.
Academic Article Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.

Search Criteria
  • Breast Neoplasms

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)